HomeCompareFCODF vs MRK

FCODF vs MRK: Dividend Comparison 2026

FCODF yields 0.38% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FCODF wins by $275.0K in total portfolio value· pulled ahead in Year 7
10 years
FCODF
FCODF
● Live price
0.38%
Share price
$1,430.00
Annual div
$5.38
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$332.7K
Annual income
$220,199.62
Full FCODF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FCODF vs MRK

📍 FCODF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFCODFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FCODF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FCODF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FCODF
Annual income on $10K today (after 15% tax)
$31.96/yr
After 10yr DRIP, annual income (after tax)
$187,169.68/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, FCODF beats the other by $178,572.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FCODF + MRK for your $10,000?

FCODF: 50%MRK: 50%
100% MRK50/50100% FCODF
Portfolio after 10yr
$195.2K
Annual income
$115,156.70/yr
Blended yield
58.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FCODF
No analyst data
Altman Z
2.3
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FCODF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFCODFMRK
Forward yield0.38%2.81%
Annual dividend / share$5.38$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$332.7K$57.7K
Annual income after 10y$220,199.62$10,113.78
Total dividends collected$303.2K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FCODF vs MRK ($10,000, DRIP)

YearFCODF PortfolioFCODF Income/yrMRK PortfolioMRK Income/yrGap
1$10,775$75.21$11,213$373.04$438.00MRK
2$11,681$151.47$12,667$512.06$986.00MRK
3$12,806$306.92$14,439$708.14$1.6KMRK
4$14,331$628.91$16,640$988.16$2.3KMRK
5$16,650$1,315.55$19,432$1,394.07$2.8KMRK
6$20,672$2,856.83$23,057$1,992.90$2.4KMRK
7← crossover$28,749$6,629.91$27,889$2,894.79+$860.00FCODF
8$47,996$17,234.33$34,518$4,286.29+$13.5KFCODF
9$105,135$53,780.17$43,912$6,494.35+$61.2KFCODF
10$332,694$220,199.62$57,714$10,113.78+$275.0KFCODF

FCODF vs MRK: Complete Analysis 2026

FCODFStock

Compagnie de l'Odet operates in the transport and logistics, and communication sectors in France, Africa, the Americas, the Asia-Pacific, and other European countries. The company operates through Transportation and Logistics, Oil Logistics, Communication, and Electricity Storage and Systems segments. The Transportation and Logistics segment provides maritime, and air transport and logistics services. The Oil Logistics segment distributes oil products. The Communication segment engages in the sale of recorded music on physical media or digital form; exploitation of copyrights and services to artists; editing and distribution of pay and free television channels; production, sale, and distribution of motion pictures and TV series; design and publishing of downloadable video games for mobiles and consoles; and provision of ticketing services, and communication and advertising agency consultancy. The Electricity Storage and Systems segment produces and sells electric batteries for electric vehicles, terminals and specialized systems, and plastic films, as well as telecommunications activities. It also manages a portfolio of financial investments. The company was formerly known as Financière de l'Odet SA and changed its name to Compagnie de l'Odet in May 2021. The company was incorporated in 1929 and is headquartered in Paris, France. Compagnie de l'Odet is a subsidiary of Bolloré SE.

Full FCODF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FCODF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FCODF vs SCHDFCODF vs JEPIFCODF vs OFCODF vs KOFCODF vs MAINFCODF vs JNJFCODF vs ABBVFCODF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.